CVE-2023-38958
CVE-2023-38958 is a medium-severity vulnerability in Zkteco Bioaccess Ivs with a CVSS 3.x base score of 5.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-863.
Key facts
- Severity: Medium (CVSS 3.x base score 5.3)
- EPSS exploit prediction: 0% (32nd percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-863
- Affected product: Zkteco Bioaccess Ivs
- Published:
- Last modified:
Description
An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.
Frequently asked questions
- What is CVE-2023-38958?
- An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.
- How severe is CVE-2023-38958?
- CVE-2023-38958 has a CVSS 3.x base score of 5.3, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity low, and availability none.
- Is CVE-2023-38958 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (32nd percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-38958?
- CVE-2023-38958 affects Zkteco Bioaccess Ivs. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2023-38958?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2023-38958 published?
- CVE-2023-38958 was published on 2023-08-03 and last updated on 2026-07-09.
References
Affected products (1)
- cpe:2.3:a:zkteco:bioaccess_ivs:3.3.1:*:*:*:*:*:*:*
More vulnerabilities in Zkteco Bioaccess Ivs
- CVE-2023-38954 — Critical (CVSS 9.8): ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.
- CVE-2023-38956 — High (CVSS 7.5): A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files…
- CVE-2023-38955 — High (CVSS 7.5): ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices,…
All CVEs affecting Zkteco Bioaccess Ivs →
Other CWE-863 (Incorrect Authorization) vulnerabilities
- CVE-2026-121352 — Critical (CVSS 10.0): Adobe Connect is affected by an Incorrect Authorization vulnerability that could result in privilege escalation. An…
- CVE-2026-89103 — Critical (CVSS 10.0): SAP Gateway activates the default Access Control List with high privileges allowing categorization of external attacker…
- CVE-2026-111812 — Critical (CVSS 10.0): Apache Traffic Server's origin_server_auth plugin lets a client force signing of attacker-chosen AWS request headers…
- CVE-2026-90532 — Critical (CVSS 10.0): Adobe Experience Manager is affected by an Incorrect Authorization vulnerability that could result in arbitrary code…
- CVE-2026-48383 — Critical (CVSS 10.0): Adobe Experience Manager is affected by an Incorrect Authorization vulnerability that could result in arbitrary code…
- CVE-2026-48382 — Critical (CVSS 10.0): Adobe Experience Manager is affected by an Incorrect Authorization vulnerability that could result in arbitrary code…
Browse all CWE-863 (Incorrect Authorization) vulnerabilities →